A pilot study assessing the association of the genetic (rs1800497 ANKK1 c.2137G > A) variant with weight loss in patients treated with Naltrexone/bupropion
Latest Information Update: 29 Jul 2021
At a glance
- Drugs Naltrexone/bupropion (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 29 Jul 2021 New trial record